Literature DB >> 24211452

Prefrontal cognitive deficits in mice with altered cerebral cortical GABAergic interneurons.

Gregory B Bissonette1, Mihyun H Bae2, Tejas Suresh2, David E Jaffe2, Elizabeth M Powell3.   

Abstract

Alterations of inhibitory GABAergic neurons are implicated in multiple psychiatric and neurological disorders, including schizophrenia, autism and epilepsy. In particular, interneuron deficits in prefrontal areas, along with presumed decreased inhibition, have been reported in several human patients. The majority of forebrain GABAergic interneurons arise from a single subcortical source before migrating to their final regional destination. Factors that govern the interneuron populations have been identified, demonstrating that a single gene mutation may globally affect forebrain structures or a single area. In particular, mice lacking the urokinase plasminogen activator receptor (Plaur) gene have decreased GABAergic interneurons in frontal and parietal, but not caudal, cortical regions. Plaur assists in the activation of hepatocyte growth factor/scatter factor (HGF/SF), and several of the interneuron deficits are correlated with decreased levels of HGF/SF. In some cortical regions, the interneuron deficit can be remediated by endogenous overexpression of HGF/SF. In this study, we demonstrate decreased parvalbumin-expressing interneurons in the medial frontal cortex, but not in the hippocampus or basal lateral amygdala in the Plaur null mouse. The Plaur null mouse demonstrates impaired medial frontal cortical function in extinction of cued fear conditioning and the inability to form attentional sets. Endogenous HGF/SF overexpression increased the number of PV-expressing cells in medial frontal cortical areas to levels greater than found in wildtype mice, but did not remediate the behavioral deficits. These data suggest that proper medial frontal cortical function is dependent upon optimum levels of inhibition and that a deficit or excess of interneuron numbers impairs normal cognition.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attentional set; Cued extinction; EDS; GABA; HGF; HGF/SF; IDS; ID–ED; ID–ED shift; MFC; Morris water maze; OFC; PCR; PV; Plaur; SEM; Urokinase plasminogen activator receptor; extradimensional shift; gamma-aminobutyric acid; gene for hepatocyte growth factor/scatter factor; gene that encodes urokinase plasminogen activator receptor; hepatocyte growth factor/scatter factor; intradimensional shift; intradimensional–extradimensional (shift); medial frontal cortex; orbital frontal cortex; parvalbumin; polymerase chain reaction; standard error of the mean

Mesh:

Substances:

Year:  2013        PMID: 24211452      PMCID: PMC3874795          DOI: 10.1016/j.bbr.2013.10.051

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  64 in total

1.  The caudal ganglionic eminence is a source of distinct cortical and subcortical cell populations.

Authors:  Susana Nery; Gord Fishell; Joshua G Corbin
Journal:  Nat Neurosci       Date:  2002-12       Impact factor: 24.884

2.  Lesions of the orbital prefrontal cortex impair the formation of attentional set in rats.

Authors:  E Alexander Chase; David S Tait; Verity J Brown
Journal:  Eur J Neurosci       Date:  2012-06-04       Impact factor: 3.386

3.  Genetic disruption of Met signaling impairs GABAergic striatal development and cognition.

Authors:  G J Martins; M Shahrokh; E M Powell
Journal:  Neuroscience       Date:  2010-12-31       Impact factor: 3.590

4.  Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention.

Authors:  Sara B Glickstein; Deirdre A Desteno; Patrick R Hof; Claudia Schmauss
Journal:  Cereb Cortex       Date:  2004-11-10       Impact factor: 5.357

5.  Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon.

Authors:  E M Powell; W M Mars; P Levitt
Journal:  Neuron       Date:  2001-04       Impact factor: 17.173

6.  Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.

Authors:  T Hashimoto; D Arion; T Unger; J G Maldonado-Avilés; H M Morris; D W Volk; K Mirnics; D A Lewis
Journal:  Mol Psychiatry       Date:  2007-05-01       Impact factor: 15.992

7.  Lesions of the basal forebrain impair reversal learning but not shifting of attentional set in rats.

Authors:  David Scott Tait; Verity J Brown
Journal:  Behav Brain Res       Date:  2007-09-04       Impact factor: 3.332

8.  Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.

Authors:  Martin R Gluck; Rohan G Thomas; Kenneth L Davis; Vahram Haroutunian
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

9.  Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice.

Authors:  Gregory B Bissonette; Gabriela J Martins; Theresa M Franz; Elizabeth S Harper; Geoffrey Schoenbaum; Elizabeth M Powell
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

10.  Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain.

Authors:  Kathryn Hefner; Nigel Whittle; Jaynann Juhasz; Maxine Norcross; Rose-Marie Karlsson; Lisa M Saksida; Timothy J Bussey; Nicolas Singewald; Andrew Holmes
Journal:  J Neurosci       Date:  2008-08-06       Impact factor: 6.167

View more
  31 in total

1.  Prefrontal cortical GABAergic signaling and impaired behavioral flexibility in aged F344 rats.

Authors:  B S Beas; J A McQuail; C Ban Uelos; B Setlow; J L Bizon
Journal:  Neuroscience       Date:  2016-02-09       Impact factor: 3.590

2.  Rule encoding in dorsal striatum impacts action selection.

Authors:  Gregory B Bissonette; Matthew R Roesch
Journal:  Eur J Neurosci       Date:  2015-09-02       Impact factor: 3.386

3.  Long-range GABAergic neurons in the prefrontal cortex modulate behavior.

Authors:  Christian Bravo-Rivera; Maria M Diehl; Ciorana Roman-Ortiz; Jose Rodriguez-Romaguera; Luis E Rosas-Vidal; Hector Bravo-Rivera; Kelvin Quiñones-Laracuente; Fabricio H Do-Monte
Journal:  J Neurophysiol       Date:  2014-12-17       Impact factor: 2.714

Review 4.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

5.  Autism as a sequence: from heterochronic germinal cell divisions to abnormalities of cell migration and cortical dysplasias.

Authors:  Manuel F Casanova
Journal:  Med Hypotheses       Date:  2014-04-13       Impact factor: 1.538

6.  GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.

Authors:  J L Silverman; M C Pride; J E Hayes; K R Puhger; H M Butler-Struben; S Baker; J N Crawley
Journal:  Neuropsychopharmacology       Date:  2015-03-10       Impact factor: 7.853

Review 7.  Neurophysiology of rule switching in the corticostriatal circuit.

Authors:  G B Bissonette; M R Roesch
Journal:  Neuroscience       Date:  2016-02-03       Impact factor: 3.590

Review 8.  Medial prefrontal cortex in neurological diseases.

Authors:  Pan Xu; Ai Chen; Yipeng Li; Xuezhi Xing; Hui Lu
Journal:  Physiol Genomics       Date:  2019-08-02       Impact factor: 3.107

9.  Touchscreen learning deficits and normal social approach behavior in the Shank3B model of Phelan-McDermid Syndrome and autism.

Authors:  Nycole A Copping; Elizabeth L Berg; Gillian M Foley; Melanie D Schaffler; Beth L Onaga; Nathalie Buscher; Jill L Silverman; Mu Yang
Journal:  Neuroscience       Date:  2016-05-14       Impact factor: 3.590

10.  Multimodal and Site-Specific Plasticity of Amygdala Parvalbumin Interneurons after Fear Learning.

Authors:  Elizabeth K Lucas; Anita M Jegarl; Hirofumi Morishita; Roger L Clem
Journal:  Neuron       Date:  2016-07-14       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.